| Year |
Citation |
Score |
| 2018 |
Carrier EJ, Galindo CL, Kim K, Macias-Perez I, Pavliv L, Shin JJ, Knollmann BC, Soslow JH, Markham LW, West JD. Abstract 397: Preventing Cardiomyopathy of Muscular Dystrophy Through Antagonism of the Thromboxane/Prostanoid Receptor Circulation Research. 123. DOI: 10.1161/Res.123.Suppl_1.397 |
0.356 |
|
| 2008 |
Macias-Perez I, Borza C, Chen X, Yan X, Ibanez R, Mernaugh G, Matrisian LM, Zent R, Pozzi A. Loss of integrin alpha1beta1 ameliorates Kras-induced lung cancer. Cancer Research. 68: 6127-35. PMID 18676835 DOI: 10.1158/0008-5472.Can-08-1395 |
0.523 |
|
| 2008 |
Macias-Perez IM, Zent R, Carmosino M, Breyer MD, Breyer RM, Pozzi A. Mouse EP3 alpha, beta, and gamma receptor variants reduce tumor cell proliferation and tumorigenesis in vivo. The Journal of Biological Chemistry. 283: 12538-45. PMID 18230618 DOI: 10.1074/Jbc.M800105200 |
0.557 |
|
| 2007 |
Rao R, Redha R, Macias-Perez I, Su Y, Hao C, Zent R, Breyer MD, Pozzi A. Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo. The Journal of Biological Chemistry. 282: 16959-68. PMID 17401137 DOI: 10.1074/Jbc.M701214200 |
0.569 |
|
| 2005 |
Pozzi A, Macias-Perez I, Abair T, Wei S, Su Y, Zent R, Falck JR, Capdevila JH. Characterization of 5,6- and 8,9-epoxyeicosatrienoic acids (5,6- and 8,9-EET) as potent in vivo angiogenic lipids. The Journal of Biological Chemistry. 280: 27138-46. PMID 15917237 DOI: 10.1074/Jbc.M501730200 |
0.527 |
|
| 2004 |
Pozzi A, Yan X, Macias-Perez I, Wei S, Hata AN, Breyer RM, Morrow JD, Capdevila JH. Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation. The Journal of Biological Chemistry. 279: 29797-804. PMID 15123663 DOI: 10.1074/Jbc.M313989200 |
0.558 |
|
| Show low-probability matches. |